Frontier Wealth Management LLC Clovis Oncology, Inc. Transaction History

Frontier Wealth Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.06 - $5.8 $111,954 - $159,935	-27,575 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.02 - $7.05 $5 - $7	1 Added 0.0%	27,575 $160,000
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $132,630 - $285,115	27,574 New	27,574 $194,000
Q3 2020 Nov 13, 2020	SELL	$4.82 - $7.72 $187,372 - $300,107	-38,874 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $462,597 - $787,797	-81,300 Reduced 67.65%	38,874 $262,000
Q4 2019 Feb 13, 2020	BUY	$3.0 - $16.43 $360,522 - $1.97 Million	120,174 New	120,174 $1.25 Million
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $248,230 - $697,308	-21,344 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $203,122 - $342,203	-6,916 Reduced 24.47%	21,344 $627,000
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $49,420 - $73,320	1,175 Added 4.34%	28,260 $1.29 Million
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $18,293 - $24,717	-365 Reduced 1.33%	27,085 $1.43 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $270,566 - $396,680	4,690 Added 20.61%	27,450 $1.87 Million
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $56,086 - $70,816	835 Added 3.81%	22,760 $1.88 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,925	21,925 $2.05 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Wealth Management LLC with notifications on news.